Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2017 07:30 ET | Source: Fuisz Pharma LLC

Fuisz Announces Allowance for Keystone Patent in the Field of Breath-based Medical Diagnostics

Bethlehem, PA, June 05, 2017 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today that it has received a notice of allowance for the patent application titled “Method and System to Amplify and...
May 30, 2017 11:00 ET | Source: Allied Market Research

Global DNA Sequencing Market Expected to Reach $18,284 Million by 2023 - Allied Market Research

Portland, United States, May 30, 2017 (GLOBE NEWSWIRE) -- According to a new report published by Allied Market Research, titled, "DNA Sequencing Market : Global Opportunity Analysis and Industry...
May 30, 2017 10:30 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017

TUCSON, Ariz., May 30, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at...
May 15, 2017 17:14 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering

TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its...
May 09, 2017 21:59 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock

TUCSON, Ariz., May 09, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 2,750,000 shares of its common stock,...
April 18, 2017 17:53 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd

TUCSON, Ariz., April 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial...
March 29, 2017 08:02 ET | Source: DiamiR Biosciences Corp.

DiamiR Announces Oral Presentation at AD/PD(TM) 2017

MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...
March 15, 2017 12:15 ET | Source: Accelerate Diagnostics, Inc.

Accelerate Diagnostics Names Tom Brown to Board of Directors

TUCSON, Ariz., March 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Tom Brown to the company’s board of directors. His appointment is effective March 14,...
March 15, 2017 08:02 ET | Source: DiamiR Biosciences Corp.

DiamiR Awarded $2.75M Grant for Development of CogniMIR(TM) for Early Detection of Alzheimer's Disease

MONMOUTH JUNCTION, NJ--(Marketwired - March 15, 2017) - DiamiR, LLC, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute...
March 08, 2017 07:30 ET | Source: BCC Research

Animal Therapeutics and Diagnostics Markets to Lope Along at 3.6% CAGR, Predicts BCC Research

Wellesley, Mass, March 08, 2017 (GLOBE NEWSWIRE) -- Growing awareness, education, and demand for high-quality animal products is driving modest growth in the market for animal therapeutics and...